14 mar 2022
Hidradenitis Suppurativa: Where We Are and Where We Are Going
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease primarily affecting apocrine gland-rich areas of the body.
14 mar 2022
Efficacy and Safety of Upadacitinib in Patients With Moderate to Severe Atopic Dermatitis
Primary results from the Measure Up 1 and Measure Up 2 studies demonstrated upadacitinib efficacy and safety through 16 weeks in patients with atopic dermatitis.
10 mar 2022
Dermatologist for Riyadh
Meds Link is searching for his client- a modern facility specialized in aesthetic and cosmetic surgery
07 mar 2022
Dermatofibrosarcoma Protuberans
Dermatofibrosarcoma Protuberans: Experience at a Third-Level Referral Cente
07 mar 2022
Alopecia in COVID-19 Patients
COVID-19 infection is associated with androgenetic alopecia
07 mar 2022
2021 European guideline on the management of Mycoplasma
Mycoplasma genitalium infection contributes to 10-35% of non-chlamydial non-gonococcal urethritis in men.
28 feb 2022
How to spot a basosquamous carcinoma
Basosquamous carcinoma (BSC) is a relatively rare type of neoplasm originating from basal cell carcinoma with features of squamous differentiation.
28 feb 2022
Dermatoscopic and clinical features
Congenital nail matrix nevi (NMN) are difficult to diagnose because they feature clinical characteristics suggestive of adult subungual melanoma.
28 feb 2022
2021 European guideline
Mycoplasma genitalium infection contributes to 10-35% of non-chlamydial non-gonococcal urethritis in men. In women
25 feb 2022
Accordo congiunto sulla prevenzione dei tumori cutanei pubblicato dalla EADV
European Academy of Dermatology and Venereology
23 feb 2022
GIDV - Anno 2022 - Volume 157 - Numero 1
Febbraio 2022 - Giornale Italiano di Dermatologia e Venereologia
23 feb 2022
GIDV - Anno 2021 - Volume 156 - Numero 6
Dicembre 2021 - Giornale Italiano di Dermatologia e Venereologia
21 feb 2022
Thalidomide in dermatology
Thalidomide is an effective agent to treat over 25 seemingly unrelated dermatological conditions that have an inflammatory or autoimmune basis.
21 feb 2022
Systemic Treatment of Cutaneous Adverse Events
As treatment with immune checkpoint inhibitors (CPIs) for cancer increases, so has the incidence of immune-related cutaneous adverse events (irCAEs).
21 feb 2022
Association between vitiligo and hearing loss
Vitiligo is a common depigmenting disorder caused by the autoimmune destruction of melanocytes.
17 feb 2022
Tatuaggi e le nuove normative europee
Giro di vite per i tatuaggi. Dal 4 gennaio il nuovo regolamento Europeo
15 feb 2022
AILS – Associazione Italiana Lotta alla Sclerodermia ODV
AILS – Associazione Italiana Lotta alla Sclerodermia ODV celebra quest’anno il proprio ventennale
14 feb 2022
Treatment of retronychia
Retronychia is an inflammatory disorder typical of the great toes characterized by arrested nail growth, ingrowth of the nail plate into the proximal nail fold and paronychia.
14 feb 2022
Biologic therapies associated with development of palmoplantar pustulosis
Palmoplantar pustulosis (PPP) and palmoplantar pustular psoriasis (PPPP) are chronic inflammatory skin conditions characterized by eruptions of sterile pustules on the palms and/or soles.
14 feb 2022
Efficacy and safety of topical finasteride spray solution for male androgenetic alopecia
Oral finasteride is a well-established treatment for men with androgenetic alopecia (AGA), but long-term therapy is not always acceptable to patients.